Keeping an eye on cholesterol is one of the most important parts of protecting heart health, but according to the report, the usual LDL blood test may not tell the whole story. Cardiologists are pointing to ApoB testing as a low-cost add-on that can help provide a more complete view of the particles linked to plaque buildup in the arteries.
The standard lipid panel estimates LDL levels, but that calculation can be less reliable in people with issues such as diabetes, metabolic syndrome, or high triglycerides. ApoB testing takes a different approach by measuring apolipoprotein B, a protein found on plaque-causing particles, including LDL. Because each harmful particle carries its own ApoB, the test gives a direct count of those particles rather than an estimate.
What the research suggests
According to the report, a JAMA study used computer modeling to compare three common ways of guiding cholesterol treatment: LDL cholesterol, non-HDL cholesterol, and ApoB. In the simulation of 250,000 American adults at risk for heart disease, ApoB-guided treatment was associated with fewer heart attacks and strokes, longer life expectancy, and lower future healthcare costs. The study authors said those benefits came at a price that represented good value for U.S. healthcare payers.
Doctors quoted in the report said ApoB is especially useful when LDL and non-HDL numbers do not line up, or when triglycerides, obesity, or metabolic syndrome are part of the picture. It can also help fine-tune treatment for people already taking cholesterol-lowering medication, since a good LDL reading does not always mean the plaque-causing particle count is low. While the test is available and relatively inexpensive, it is not always covered by insurance, though coverage is improving as more guidelines from major heart organizations recommend it more broadly.
For people looking to get a fuller snapshot of their heart health, the report suggests ApoB is worth bringing up at the next doctor’s visit. In some cases, clinicians may also consider lipoprotein(a) as a one-time screening test to help assess plaque risk even further.
Source: menshealth.com
